Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial

AIMS: This study aimed to assess safety and cardiovascular outcomes of dronedarone in patients with paroxysmal or persistent atrial fibrillation (AF) with coronary heart disease (CHD). Coronary heart disease is prevalent among AF patients and limits antiarrhythmic drug use because of their potential...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Pisters, Ron, Hohnloser, Stefan H., Connolly, Stuart J., Torp-Pedersen, Christian, Naditch-Brûlé, Lisa, Page, Richard L., Crijns, Harry J.G.M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2014
Aiheet:
Clinical Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3905706/
https://ncbi.nlm.nih.gov/pubmed/24072451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/europace/eut293
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia